Bioventix PLC
LSE:BVXP
Bioventix PLC
Cash from Financing Activities
Bioventix PLC
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bioventix PLC
LSE:BVXP
|
Cash from Financing Activities
-£7.8m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Cash from Financing Activities
$21.1m
|
CAGR 3-Years
149%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Cash from Financing Activities
-$883k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Cash from Financing Activities
$250m
|
CAGR 3-Years
58%
|
CAGR 5-Years
58%
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Cash from Financing Activities
£34.3m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
221%
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Cash from Financing Activities
-£20.5m
|
CAGR 3-Years
5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Bioventix PLC's Cash from Financing Activities?
Cash from Financing Activities
-7.8m
GBP
Based on the financial report for Dec 31, 2023, Bioventix PLC's Cash from Financing Activities amounts to -7.8m GBP.
What is Bioventix PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-6%
Over the last year, the Cash from Financing Activities growth was 2%. The average annual Cash from Financing Activities growth rates for Bioventix PLC have been -7% over the past three years , -6% over the past five years .